Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 429.20
-8.30 (-1.90%)
Aug 10, 2026, 4:59 PM CET
Coloplast Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 28,045 | 27,874 | 27,030 | 24,500 | 22,579 | 19,426 | |
Revenue Growth | 0.90% | 3.12% | 10.33% | 8.51% | 16.23% | 4.76% |
Cost of Revenue | 9,126 | 8,929 | 8,761 | 8,172 | 7,050 | 6,113 |
Gross Profit | 18,919 | 18,945 | 18,269 | 16,328 | 15,529 | 13,313 |
Selling, General & Admin | 10,480 | 10,420 | 10,069 | 8,633 | 7,802 | 6,247 |
Research & Development | 989 | 946 | 913 | 872 | 866 | 755 |
Other Operating Expenses | 3,284 | 378 | -33 | 52 | 422 | 156 |
Total Operating Expenses | 14,753 | 11,744 | 10,949 | 9,557 | 9,090 | 7,158 |
Operating Income | 4,166 | 7,201 | 7,320 | 6,771 | 6,439 | 6,155 |
Interest Income | 263 | 107 | 175 | 191 | 119 | 137 |
Interest Expense | -985 | -1,151 | -1,100 | -937 | -431 | -59 |
Total Non-Operating Income (Expense) | -722 | -1,044 | -925 | -746 | -312 | 78 |
Pretax Income | 3,444 | 6,157 | 6,395 | 6,025 | 6,127 | 6,233 |
Provision for Income Taxes | 1,338 | 2,521 | 1,343 | 1,242 | 1,421 | 1,408 |
Net Income | 2,106 | 3,636 | 5,052 | 4,783 | 4,706 | 4,825 |
Net Income to Common | 2,106 | 3,636 | 5,052 | 4,783 | 4,706 | 4,825 |
Net Income Growth | -53.65% | -28.03% | 5.62% | 1.64% | -2.47% | 14.96% |
Shares Outstanding (Basic) | 225 | 225 | 225 | 215 | 213 | 213 |
Shares Outstanding (Diluted) | 225 | 225 | 225 | 216 | 213 | 213 |
Shares Change | 0.09% | 0.22% | 4.36% | 1.27% | -0.19% | -0.05% |
EPS (Basic) | 9.34 | 16.13 | 22.46 | 22.21 | 22.14 | 22.67 |
EPS (Diluted) | 9.34 | 16.13 | 22.46 | 22.20 | 22.11 | 22.63 |
EPS Growth | -53.72% | -28.18% | 1.17% | 0.41% | -2.30% | 15.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 6,071 | 5,339 | 1,600 | 3,206 | 4,172 | 4,371 |
Free Cash Flow Growth | 20.72% | 233.69% | -50.09% | -23.15% | -4.55% | 11.71% |
Free Cash Flow Per Share | 26.95 | 23.69 | 7.11 | 14.88 | 19.61 | 20.50 |
Dividends Per Share | 23.000 | 23.000 | 22.000 | 21.000 | 20.000 | 19.000 |
Dividend Growth | 4.54% | 4.54% | 4.76% | 5.00% | 5.26% | 5.56% |
Gross Margin | 67.46% | 67.97% | 67.59% | 66.64% | 68.78% | 68.53% |
Operating Margin | 14.85% | 25.83% | 27.08% | 27.64% | 28.52% | 31.68% |
Profit Margin | 7.51% | 13.04% | 18.69% | 19.52% | 20.84% | 24.84% |
FCF Margin | 21.65% | 19.15% | 5.92% | 13.09% | 18.48% | 22.50% |
EBITDA | 8,641 | 8,654 | 8,610 | 7,840 | 7,369 | 6,947 |
EBITDA Margin | 30.81% | 31.05% | 31.85% | 32.00% | 32.64% | 35.76% |
EBIT | 4,166 | 7,201 | 7,320 | 6,771 | 6,439 | 6,155 |
EBIT Margin | 14.85% | 25.83% | 27.08% | 27.64% | 28.52% | 31.68% |
Effective Tax Rate | 38.85% | 40.95% | 21.00% | 20.61% | 23.19% | 22.59% |